CSNK1A1 and myelodysplastic syndrome: This was proposed to be due to synthetic lethality that occurs only in del(5q) MDS with haploinsufficient CSNK1A1, which is more likely to fail in AML since these leukemias with chromosome 5q abnormalities typically occur with other cytogenetic changes and often carry TP53 mutations16.